Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT

Neuroradiology Journal

Volumn 27, Issue 1, 2014, Pages 13-21

  Tripathi, Madhavi ^a   Tripathi, Manjari ^a   Damle, Nishikant ^a   Kushwaha, Suman ^b   Jaimini, Abhinav ^c   D'Souza, Maria M ^c   Sharma, Rajnish ^c   Saw, Sanjiv ^c   Mondal, Anupam ^c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

^c INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

AD; DLBD; FDG PET; FTD; Vascular dementia

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; GLUCOSE METABOLISM; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MULTIINFARCT DEMENTIA; PHENOTYPE; PHYSICIAN; PROSPECTIVE STUDY;

AD; DLBD; FDG-PET; FTD; VASCULAR DEMENTIA;

AGED; ALZHEIMER DISEASE; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTOTEMPORAL DEMENTIA; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84898442979     PISSN: 19714009     EISSN: None     Source Type: Journal    
DOI: 10.15274/NRJ-2014-10002     Document Type: Article

References (24)

1. Foster NL, Heidebrink JL, Clark CM, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain. 2007; 130 (Pt 10): 2616-2635. (Pubitemid 47511706)
2. Minoshima S, Foster NL, Sima AA, et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with Autopsy confirmation. Ann Neurol. 2001; 50 (3): 358-365. (Pubitemid 32848738)
3. Silverman DH, Small GW, Chang CY, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 2001; 286 (17): 2120-2127. (Pubitemid 34041597)
4. Albin RL, Minoshima S, D'Amato CJ, et al. Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 1996; 47 (2): 462-466. (Pubitemid 26324044)
5. Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med. 1998; 39 (11): 1875-1878. (Pubitemid 28518885)
6. Diehl-Schmid J, Grimmer T, Drzezga A, et al. Longitudinal changes of cerebral glucose metabolism in semantic dementia. Dement Geriatr Cogn Disord. 2006; 22: 346-351. (Pubitemid 44651450)
7. Medicare National Coverage Determinations Manual: Chapter 1, Part 4 (Sections 200-310.1) - Coverage Determinations. Centers for Medicare and Medicaid Services Web site. Available at: http://www.cms.gov/Regulations-and- Guidance/Guidance/Manuals/Downloads/ncd103c1-Part4.pdf.
8. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12 (3): 189-198.
9. Berg L. Clinical Dementia Rating (CDR). Psychopharmacol Bull. 1988; 24 (4): 637-639. (Pubitemid 19054369)
10. Sharma R, Tripathi M, D'Souza MM, et al. Spectrum of neurocognitive dysfunction in Indian population on FDG PET/CT imaging. Indian J Nucl Med. 2011; 26 (2): 67-77.
11. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology. 1984; 34 (7): 939-944. (Pubitemid 14076461)
12. Miller BL, Ikonte C, Ponton M, et al. A study of Lund-Manchester research criteria for frontotemporal dementia: Clinical and single-photon emission CT correlations. Neurology 1997; 48 (4): 937-942.
13. Roman GC, Tatemichi TK, Erkinjuntti T. Vascular dementia: Diagnostic criteria for research studies - A report on the NINDS-AIREN international workshop. Neurology. 1993; 43 (2): 250-260. (Pubitemid 23060253)
14. Laforce R Jr, Buteau JP, Paquet N, et al. The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: a retrospective memory clinic study. Am J Alzheimers Dis Other Demen. 2010; 25 (4): 324-332.
15. Mc Keith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology. 2005; 65 (12): 1863-1872. (Pubitemid 43970103)
16. Panegyres PK, Rogers JM, McCarthy M, et al. Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study. BMC Neurol. 2009; 9: 41.
17. Jagust W, Reed B, Mungas D, et al. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology. 2007; 69 (9): 871-877. (Pubitemid 47329586)
18. Hodges JR, Patterson K, Oxbury S, et al. Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain. 1992; 115 (Pt 6): 1783-1806. (Pubitemid 23054865)
19. Ransmayr G, Wenning GK, Seppi K, et al. Dementia with Lewy bodies. Nervenarzt 2000; 71 (12): 929-935.
20. Mielke R, Heiss WD. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia. J Neural Transm Suppl. 1998; 53: 237-250. (Pubitemid 28361784)
21. Xing XW, Zhang JT, Zhu F, et al. Comparison of diffusion-weighted MRI with 18F-fluorodeoxyglucosepositron emission tomography/CT and electroencephalography in sporadic Creutzfeldt-Jakob disease. J Clin Neurosci. 2012; 19 (10): 1354-1357.
22. Tripathi M, Tripathi M, Vibha D, et al. Tc-99m ethylcysteinate dimer SPECT in the differential diagnosis of dementias. Neurol India. 2010; 58: 857-862.
23. Patwardhan MB, McCrory DC, Matchar DB, et al. Alzheimer disease: operating characteristics of PET - A meta-analysis. Radiology. 2004; 231 (1): 73-80. (Pubitemid 38375412)
24. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56 (9): 1143-1153. (Pubitemid 32405708)